Despite tireless efforts, we may never find a Covid-19 vaccine: UK official

Meanwhile, around half of the doctors in the UK working during the coronavirus pandemic fear for their health, according to a new survey by the Royal College of Physicians

testing, private laboratories, labs, vaccines, doctors, nurses, health, coronavirus
The death toll in the UK due to infection stan
ANI
2 min read Last Updated : May 18 2020 | 9:31 AM IST

Business Secretary Alok Sharma on Sunday said it is possible that the United Kingdom may never find a successful Covid-19 vaccine.

"...in spite of the tireless efforts of our scientist, it is possible that we may never find a successful coronavirus vaccine," Sharma said during the daily press brief in London.

However, he also added that "two of the world's frontrunners to develop a vaccine is right here in the UK, at the University of Oxford and Imperial College London."

Sharma further said, "So far the UK government has invested 47 million pounds in the Oxford and Imperial vaccine program." The Business Secretary also announced new government funding for both of the vaccine programs.

Meanwhile, around half of the doctors in the UK working during the coronavirus pandemic fear for their health, according to a new survey by the Royal College of Physicians.
 

Professor Andrew Goddard, president of the Royal College of Physicians said: "We're living through the darkest times the NHS has ever faced and this survey shows the reality of the situation facing hospital doctors at the moment."

"The lack of PPE remains their biggest concern and it is truly terrible that supply has worsened over the past three weeks rather than improved," Goddard added.
 

The death toll in the UK due to infection stands at 34,636. A total of 3,142 people tested positive for the virus in the past day, taking the count of the total cases to 243,303.

According to the Johns Hopkins University, there is at least 4,702,603 number of case of coronavirus with over 314,476 fatalities. The UK has the third-highest number of Covid-19 cases globally.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusLockdownBritainOxford UniversityhealthcareHealth crisis

Next Story